Currently out of the existing stock ratings of Scott Henry, 75 are a BUY (82.42%), 16 are a HOLD (17.58%).

Scott Henry

Work Performance Price Targets & Ratings Chart

Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 54.31% that have a potential upside of 51.13% achieved within 326 days. Previously, Scott Henry worked at ROTH.

Scott Henry’s has documented 182 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.

Wall Street Analyst Scott Henry

Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.

Average potential price target upside

of $36.08 (54.28%) on LGND (LIGAND PHARMACEUTICALS).
of $17.9 (39.28%) on LCI (LANNETT COMPANY).
of $17.02 (107.25%) on ASRT (ASSERTIO THERAPEUTICS).

ANIP ANI Pharmaceuticals CPRX Catalyst Pharmaceuticals CSBR Champions Oncology DCTH Delcath Systems LCI Lannett Company LGND Ligand Pharmaceuticals MYO Myomo RDHL Redhill Biopharma Ltd TNXP Tonix Pharmaceuticals Holding Corp VVOS Vivos Therapeutics AVDL Avadel Pharmaceuticals PLC BDSI BioDelivery Sciences International IRM Iron Mountain LMAT LeMaitre Vascular REPH Recro Pharma INVO INVO Bioscience TTNP Titan Pharmaceuticals ZSAN Zosano Pharma Corp ZYNE Zynerba Pharmaceuticals SRTS Sensus Healthcare VKTX Viking Therapeutics IONM Assure Holdings Corp ASRT Assertio Therapeutics DERM Journey Medical Corp INM InMed Pharmaceuticals KMPH KemPharm NTEC Intec Pharma Ltd SOLY Soliton RVPH Reviva Pharmaceuticals Holdings RNXT RenovoRx INDP Indaptus Therapeutics NBY NovaBay Pharmaceuticals VERO Venus Concept

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score